Loading viewer...
investor_presentation
Format: PDF investor_presentation
ASX: MSB ; Nasdaq: MESO Global Leader in Allogeneic Cellular Medicines for Inflammatory Diseases Financial Year Ended June 30, 2020
presentation
Amadeus IT Group
investor_presentation
Boyd Group